Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Marken announced today the appointment of Paul J. Rice as Vice President, Logistics, EMEA Region. Mr. Rice will be based in London but will have responsibility for the branches and associated business in Europe and Africa including: Paris, London, ...
read more
INC Research Holdings a global Phase I to IV contract research organization, has announced the retirement of James T. Ogle as Chairman of the Board of Directors and as a Director of the Company. Mr. Ogle has been a member of the INC Research Board of...
read more
The PPD clinical research business of Thermo Fisher Scientific Inc. and Matrix Clinical Trials are collaborating to bring clinical trials to patients with a decentralized clinical trial (DCT) solution.
read more
Wednesday, September 12, 2018
The FDA has announced the availability of a draft guidance for industry that is applicable to holders of approved new drug applications, ANDAs, new animal drug applications, abbreviated new animal drug applications and holders of drug master files ...
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Tuesday, October 06, 2020
Aphena Pharma Solutions has announced the addition of Matthew Prokopczyk to its leadership team as vice president of quality and regulatory affairs.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
OcyonBio announced a manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. OcyonBio is creating an advanced therapy contract development, manufacturing organization (CDMO) that provides ...
read more
Carolyn Finkle, Vice President, Global Regulatory Consulting at Catalent Pharma Solutions will present a webinar on “Biosimilars: Current Regulatory Environment and Development and Manufacturing Considerations” for the Pharmaceutical Education and ...
read more
We’re proud of our ISO 17025 accreditation as it reflects the broad scope of our capabilities. Also, it’s gratifying to know that we’re one of the very few labs, nationally, to hold accreditation for Elemental Impurities.” Quantex Laboratories’ ...
read more
W. R. Grace & Co. (Grace) announced the opening of its expanded fine chemical contract development and manufacturing (CDM) facility in South Haven, MI. Grace executives and local community leaders joined more than 200 employees at the site for a ...
read more
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organization Aenova Group from leading international investment firm BC Partners.
read more
ESTEVE has acquired Regis Technologies, a U.S.-based Contract Development and Manufacturing Organization (CDMO), headquartered in Chicago.
read more
Uman Diagnostics and Bio-Techne announced a strategic License and Supply Agreement for the antibodies used in the quantification of Nf-L on the ProteinSimple™-branded Ella™ immunoassay platform.
read more
Wednesday, September 23, 2015
Aesica, a global pharmaceutical contract development and manufacturing organization (CDMO), is pleased to announce its involvement in a renewable green initiative involving its UK, Cramlington site.
read more